Keratosis, Actinic
20
0
2
15
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
5.0%
1 terminated out of 20 trials
93.8%
+7.2% vs benchmark
30%
6 trials in Phase 3/4
53%
8 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (20)
Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy
A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis
OCT and Invasion in Cutaneous Skin Lesions
A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp
Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp
Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis
Microwave Treatment for Actinic Keratosis
A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis
A Pre-market Study to Evaluate the Performance and Safety of a Skin Preparation Device for Removal of Dry Crusty Skin
A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study
UV Sensor in Patients With Actinic Keratosis
A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors
The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy
Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage
Evaluation of Non-inferiority and Tolerability of the Device PHOS-ISTOS
IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis
Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)
Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol
Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick
Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)